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Abstract
Background.—The risk and timing of tuberculosis among recently exposed close contacts of 
patients with infectious tuberculosis are not well established.
Methods.—We prospectively enrolled patients ≥15 years of age with culture-confirmed 
pulmonary tuberculosis and their close contacts at 9 health departments in the United States and 
Canada. Close contacts were screened and cross-matched with tuberculosis registries to identify 
those who developed tuberculosis.
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Results.—Tuberculosis was diagnosed in 158 of 4490 contacts (4%) of 718 index patients with 
tuberculosis. Of tuberculosis cases among contacts, cumulative totals of 81 (51%), 119 (75%), 128 
(81%), and 145 (92%) were diagnosed by 1, 3, 6, and 12 months, respectively, after the index 
patients’ diagnosis. Tuberculosis rates among contacts were 2644, 115, 46, 69, and 25 cases per 
100 000 persons, respectively, in the 5 consecutive years after the index patients’ diagnosis. Of the 
tuberculosis cases among contacts, 121 (77%) were identified by contact investigation and 37 
(23%) by tuberculosis registry cross-match.
Conclusions.—Close contacts to infectious patients with tuberculosis had high rates of 
tuberculosis, with most disease diagnosed before or within 3 months after the index patient’ 
diagnosis. Contact investigations need to be prompt to detect tuberculosis and maximize the 
opportunity to identify and treat latent infection, to prevent disease.
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Close contacts of patients with infectious tuberculosis are at increased risk of developing 
Mycobacterium tuberculosis infection and disease [1, 2]. The risk of tuberculosis in 
individuals with latent M. tuberculosis infection (LTBI) is estimated to be 5%–10% over the 
course of a lifetime, with approximately half of cases occurring within the first 2 years after 
exposure [3–5]. These rates are from studies conducted >50 years ago, however, and the 
precise risk and timing of disease among recently exposed close contacts despite efforts to 
prevent tuberculosis by LTBI treatment are not well established.
Health departments throughout the United States and Canada conduct contact investigations 
for all patients with infectious tuberculosis to identify and treat recently exposed individuals 
with active tuberculosis and LTBI and thereby prevent further transmission of M. 
tuberculosis [1, 2]. A better understanding of the risk and timing of tuberculosis among 
recently exposed contacts has important implications for the expected yield and optimal 
timing of contact investigations.
To address this knowledge gap, we conducted a prospective study of contact investigations at 
9 sites in the United States and Canada. Tuberculosis registry cross-matches were conducted 
to identify contacts with tuberculosis diagnosed after the time of the contact investigation. 
We evaluated rates of tuberculosis among contacts with respect to the interval from the index 
cases’ diagnosis.
METHODS
Close contacts of all adults aged ≥15 years with culture-positive pulmonary tuberculosis 
were prospectively enrolled in a multicenter study from January 2002 to December 2006 at 9 
health departments (7 in the United States and 2 in Canada) in the Tuberculosis 
Epidemiologic Studies Consortium. Close contacts were defined as persons who had shared 
air space with an individual with pulmonary tuberculosis in the household or other indoor 
setting for >15 hours per week or >180 hours total during an infectious period, defined as 
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the interval from 3 months before collection of the first culture-positive sputum specimen or 
the date of onset of cough (whichever was longer) through 2 weeks after the initiation of 
appropriate antituberculosis treatment.
Contacts were screened as soon as possible after they were identified through interview of 
patients with tuberculosis and again 10–12 weeks after last exposure to the patient. 
Screening consisted of a standardized interview and tuberculin skin test (TST), with a 
positive TST result defined as a ≥5-mm induration. Chest radiography was performed for 
contacts with positive results of TST. While a standard protocol was used for conducting 
contact investigations, the staff at the study sites did not use a standard protocol for patient 
management, which included efforts to prevent secondary cases by investigation and 
treatment of contacts with LTBI. The Centers for Disease Control and Prevention’s (CDC’s) 
standard surveillance definitions for a reported case of tuberculosis were used for 
tuberculosis reporting by all study sites [6].
Contacts were cross-matched with state and provincial tuberculosis registries at the end of 
the enrollment period and annually for 4 years thereafter, with the exception of one study 
site, which cross-matched contacts annually for 2 years (the final match was in February 
2011).
The timing of tuberculosis among contacts was calculated by subtracting the tuberculosis 
diagnosis date for each index patient from the tuberculosis diagnosis date(s) for their 
contact(s), and tuberculosis rates per interval were based on the number of contacts with 
tuberculosis diagnosed in a given interval divided by the number of observed contacts who 
were disease free at the start of that interval. For contacts with exposure to >1 index case, the 
earliest index case tuberculosis diagnosis date was used.
Tuberculosis events among contacts with disease diagnosed >30 days after the index cases’ 
diagnosis were considered incident cases, and tuberculosis events diagnosed before or ≤30 
days after the index cases’ diagnosis were considered coprevalent cases.
Survival analysis (Proc Lifetest) was performed using the log-rank test to assess the effect of 
age group, TST size, and preventive therapy on disease-free survival of contacts. Statistically 
significant differences for other analyses were assessed using χ2 or Fisher exact tests. All 
analyses were performed using SAS software, version 9.2 (Statistical Analysis Software 
Institute, Cary, NC).
Approvals for human subjects research were obtained from the CDC and all project sites.
RESULTS
Characteristics of Contacts with Tuberculosis
Tuberculosis was diagnosed in 158 of 4490 close contacts (4%) identified for 718 patients 
with active pulmonary tuberculosis. Demographic and clinical characteristics of the 158 
contacts with tuberculosis (81 coprevalent cases and 77 incident cases) are presented in 
Table 1. Children 0–5 years of age represented 31% of all contacts with tuberculosis, 
including 36% of coprevalent cases and 26% of incident cases. Of the contacts with 
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tuberculosis, 121 (77%) were identified during contact investigation (including 96 of 127 
with a diagnosis after the index case), and 37 (23%) were identified by registry match; 
disease in 77 (49%) was confirmed by culture (67% of adults and 16% of children), and 
disease in 81 (51%) was diagnosed on the basis of clinical criteria.
Rates, Timing, and Risk Factors for Tuberculosis
The timing of tuberculosis diagnosis among contacts in relation to the index cases’ diagnosis 
is displayed in Figure 1. Of the contacts with tuberculosis, disease in 27 (17%), 4 (3%), and 
127 (80%) was diagnosed before, on the same day as, and after, respectively, the index 
cases’ diagnosis. Of the contacts with tuberculosis, cumulative totals of 81 (51%), 119 
(75%), 128 (81%), and 145 (92%) had tuberculosis diagnosed by 1 month, 3 months, 6 
months, and 12 months, respectively, after the index cases’ diagnosis.
Disease-free survival curves for all enrolled contacts who remained disease free, by age 
group, screening skin test results, and receipt of treatment for LTBI, are presented in Figure 
2. The proportion of children 0–5 years of age who remained disease free was lower than 
that for contacts in other age groups (P < .001; Figure 2A). In addition, there was a close 
relationship between TST size and risk of tuberculosis (Figure 2B). The risk of tuberculosis 
was lowest for contacts with a 0–4-mm induration (0.6%) and progressively increased as the 
induration diameter increased, with risks of 2.8%, 6.1%, 8.2%, and 8.9% among those with 
indurations of 5–9, 10–14, 15–19, and ≥20 mm, respectively (P < .001 for trend). Finally, the 
proportion of contacts who had a positive TST result and remained disease free was 
significantly greater among those who completed a full course of treatment for LTBI, 
compared with those who had a positive TST result and were not treated (P < .001), and was 
similar to the proportion with a negative TST result (Figure 2C). The proportion of contacts 
who remained disease free and had a positive TST result was significantly greater among 
those who initiated but did not complete treatment, compared with those who were not 
treated (P < .001), but was significantly less, compared with those who completed treatment 
(P = .03).
Table 2 presents tuberculosis rates among contacts, according to the interval between 
initiation of treatment of index cases and initiation of treatment in contacts. Tuberculosis 
rates among contacts were 2644, 115, 46, 69, and 25 cases/105 persons during years 1, 2, 3, 
4, and 5, respectively, after the index cases initiated treatment. Two additional contacts had 
tuberculosis diagnosed >5 years after the index case initiated treatment (one each in years 6 
and 8). Cumulative tuberculosis rates among the subset of TST-positive contacts with no 
treatment for LTBI (Table 3) were >5-fold higher than for all contacts (Table 2).
DISCUSSION
In a large prospective study of close contacts of patients with culture-positive pulmonary 
tuberculosis, we found that 4% of all close contacts had tuberculosis diagnosed and that, of 
these, 75% had tuberculosis diagnosed before or ≤3 months after the index cases had 
tuberculosis diagnosed. Our study represents an important update on the 1950s studies, 
which established rates of tuberculosis among contacts to be somewhat lower (1.5% over a 
7-year observation period) and identified the risk of tuberculosis to be highest in the first 2 
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years after exposure, with 48% of all cases occurring in that period [3–5, 7]. We have shown 
that recently exposed close contacts have very high rates of tuberculosis. In addition, we 
have provided important, new evidence from the modern era to demonstrate that tuberculosis 
among exposed contacts is not evenly distributed over the first 2 years after exposure but, 
instead, that most cases occur soon after exposure and are already evident at the time of 
contact investigation. These findings emphasize the importance of performing contact 
investigations immediately after identifying index cases, as a public health measure for 
detecting new cases of active tuberculosis and taking steps to interrupt transmission [1, 2, 8, 
9].
In the health departments participating in our study, contact investigations took anywhere 
from a few weeks to many months to complete. This timeline is similar to what has been 
reported in other settings for completing this complex, multistep process [2, 10, 11]. As a 
result, it is often difficult to be certain which tuberculosis cases identified at the time of 
contact investigation represent secondary transmission from the index case. In our study, we 
used ≥1 month after diagnosis of tuberculosis in the index case to distinguish incident from 
coprevalent tuberculosis diagnoses in contacts. Categorization of more than half of 
tuberculosis cases among contacts 0–5 years of age as coprevalent suggests that the true 
number of cases of secondary transmission may be somewhat higher than the number of 
cases we categorized as incident, since tuberculosis in young children is not infectious and is 
almost always the result of transmission from an adult index case.
Only 2 previous reports presented results separately for prevalent and incident tuberculosis, 
and each defined incident tuberculosis among contacts by using different intervals after the 
index patients’ diagnosis (270 and 180 days) [10, 11]. Despite these differences in 
definition, tuberculosis risks in our study were higher overall (3.5% vs 1.2% and 1.5%), for 
coprevalent tuberculosis (1.8% vs 1.0% and 1.2%), and for incident tuberculosis (1.7% vs 
0.3% and 0.3%), compared with tuberculosis risks in the 2 previous studies. The 
tuberculosis risks observed among contacts in this study were also higher than those 
reported for screening of other identified high-risk groups, including recent immigrants, 
refugees, and incarcerated populations [12–15], and considerably higher than those (range, 
0.6%–1.5%) reported in previous studies of contact investigations conducted in the United 
States, Canada, and the Netherlands [2, 10, 11, 16–19].
The higher tuberculosis rates among contacts that we observed likely reflect, at least in part, 
the fact that our study was prospective, enabling us to use a standard structured interview to 
elicit contacts and track outcomes, as well as a standard definition for contact closeness, 
based on a high minimum number of hours of exposure (>15 hours per week) to a patient 
with infectious tuberculosis, whereas previous studies have reported a retrospective analysis 
of tuberculosis program and surveillance data and have either not used hours of exposure or 
used a minimal requirement (>4 total hours) to define a contact [1, 2, 10, 11, 16–18]. The 
considerably higher LTBI rate in our study (48%), compared with rates in other recent 
reports (33% in New York City [10] and 16% in Amsterdam [11]), supports the hypothesis 
that our study methods resulted in the evaluation of contacts with a greater likelihood of 
exposure, compared with those in previous studies. Conducting registry matches to identify 
contacts who received a tuberculosis diagnosis for 4 years (and for some contacts, up to 8 
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years) after the contact investigation likely also contributed to our findings. The fact that our 
study was conducted in the context of tuberculosis control programs and included all eligible 
contacts, rather than persons who were selected and provided consent for a clinical trial, may 
be an additional factor contributing to the higher tuberculosis rates we observed, compared 
with those in 1950s public health trial reports [5]. Although it is not directly stated, it is 
likely that those reports excluded coprevalent cases of tuberculosis, in which case our 
incident tuberculosis rates (1.7%) are remarkably similar to the tuberculosis rates reported 
over 50 years ago by Ferebee (1.5%).
More than half of all cases of tuberculosis among contacts in our study were diagnosed by 1 
month and three quarters were diagnosed by 3 months after treatment initiation among index 
cases, suggesting that the opportunity to prevent many additional cases of tuberculosis in 
contacts was more time limited than previously recognized. High rates and rapid progression 
to tuberculosis were particularly notable among young children: among contacts 0–5 years 
of age, 10% developed tuberculosis, and 59% of all cases were diagnosed by 1 month and 
93% by 3 months after index case diagnosis. These findings have important implications for 
the optimal timing, expected yield, and prevention goals of contact investigations.
Our data demonstrating that tuberculosis rates among exposed contacts are highest in the 
first few months after exposure and decline rapidly thereafter are consistent with those 
reported in a meta-analysis of 203 studies in low-medium and high-income settings by Fox 
et al, who found that the greatest risk of tuberculosis occurs in the year after exposure [20]. 
Based on our data, strategies that improve the timeliness of identifying and treating recently 
exposed persons would likely have the greatest effectiveness in preventing tuberculosis. 
However, they do not preclude the importance of screening and treatment at later time 
points, particularly in groups at increased tuberculosis risk, such as persons born outside the 
United States [21], or as part of national and global efforts aimed at tuberculosis elimination 
[22, 23].
Contact investigation is a complex, multistep process involving index case interview to 
identify contacts and multiple steps to locate, screen, and provide treatment to recently 
exposed individuals [1, 2]. In an analysis of data from our study evaluating contact 
investigation processes, the average times from index case diagnosis to initial contact 
screening and start of contact treatment for LTBI were 35 days and 53 days, respectively 
[24], and in recent reports from Amsterdam and New York, the estimated times from index 
case diagnosis to completion of contact investigation and initiation of preventive therapy 
were 180 days and 270 days, respectively [10, 11]. These reports reflect the realities of the 
time requirements for implementing contact investigation, and for our report, even under 
study conditions [24]. Although our findings emphasize the importance of initiating contact 
investigations as early as possible after diagnosis in a patient with infectious tuberculosis, 
the rapid progression to disease suggests that, even with timelier contact investigations, 
tuberculosis in many contacts who receive a diagnosis in the first few months after the index 
cases’ diagnosis is unlikely to be prevented and that the number of preventable contact cases 
is thus relatively small. Nevertheless, contact investigations remain an important means of 
identifying contact cases and initiating treatment to prevent further (tertiary) transmission. 
Given the large resource implications of contact investigation and treatment for LTBI, cost-
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benefit and cost-effectiveness analyses incorporating our new estimates of disease risk over 
time may be warranted.
Determining the number and proportion of tuberculosis cases among contacts that can be 
prevented is of importance to an assessment of the potential impact of LTBI treatment 
programs, as well as for sample size considerations for clinical trials. Of the tuberculosis 
cases among contacts in our study, 27 (17%) and 4 (3%) were detected and treated earlier 
than and at the same time as, respectively, detection and treatment of tuberculosis among 
index cases, so by definition these cases could not have been prevented through contact 
investigation for the index case. A further 96 cases (60% of all cases among contacts) were 
diagnosed after the index cases received a diagnosis but during the health department contact 
investigation. Thus, only the 31 cases detected after the index case by registry match—
representing 20% of all cases among contacts in our study—are likely in theory to have been 
preventable with currently available diagnostic tests and strategies. Therefore, the rate of 
potentially preventable cases of tuberculosis in our population beyond those cases already 
prevented by traditional contact investigation was 0.7% (in 31 of 4490 contacts) over a 
follow-up period of up to 8 years. The rate of preventable tuberculosis cases was somewhat 
higher when limiting the analysis to TST-positive contacts (1.3% [20 of 1505]). Based on 
these findings, sample size requirements for clinical trials of preventive chemotherapeutic 
agents will be considerably higher than previously estimated [25]. These findings also may 
help explain the much lower than expected disease event rate in a recent clinical trial of 
preventive chemotherapeutic agents [25].
In addition to sample size considerations, the rates of tuberculosis over time among contacts 
in our study also have important implications for the methods, comparability of study arms, 
and length of follow-up for clinical trials of chemotherapeutic agents to treat LTBI. Our data 
demonstrate that the risk of tuberculosis in contacts following exposure varies considerably 
over time, with the highest risk immediately following the end of exposure and a rapid and 
progressive decrease in risk in the following months. Tuberculosis risks for all contacts fell 
from 2% (88 of 4459) in the first 3 months to 0.2% (9 of 4371) in the subsequent 3 months 
after index case diagnosis, for a decrease of 90%. Similarly, among the subset of TST-
positive contacts who did not initiate treatment for LTBI, the risks of tuberculosis dropped 
from 13% (65 of 482) in the first 3 months to 2% (8 of 417) in the following 3 months, for a 
decrease of 85%. These findings have important implications for steps to ensure the 
comparability of tuberculosis risks in clinical trial study arms, suggesting the need to control 
not only for recent versus remote exposure, but also for time since last exposure among 
persons with recent exposure. In our study, 81% of all tuberculosis cases among contacts 
were diagnosed by 6 months and 93% by 12 months after index cases received a diagnosis. 
Thus, our findings suggest that it may be possible to shorten the follow-up time for patients 
enrolled in clinical trials, from the usual 2 years [25] to 1 year or even 6 months.
Despite a rapid decline in the risk of tuberculosis over time, higher rates of tuberculosis were 
observed among close contacts in our study than was expected in the general population [26] 
for at least 5 years after index cases’ diagnosis, demonstrating that close contacts remain a 
high-risk population well beyond the time of exposure to an infectious case and initial 
contact investigation. This finding underscores the importance of educating persons who 
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have been exposed to a patient with infectious tuberculosis about the ongoing risk of 
developing tuberculosis, the symptoms of tuberculosis, and the need to seek prompt medical 
evaluation if symptoms occur. It also highlights the need for greater awareness on the part of 
the medical community about the importance of asking about past and recent contacts of 
patients with infectious tuberculosis and of considering tuberculosis when evaluating 
patients with a history of close contact to patients with infectious tuberculosis. Furthermore, 
this finding suggests that periodic evaluation of contacts for several years after contact 
investigation could be a productive activity, particularly for contacts at highest risk of 
tuberculosis. This strategy may be particularly important for contacts who do not initiate 
treatment for LTBI.
The incomplete human immunodeficiency virus (HIV) testing data for many contacts is a 
study limitation. Although one of our 9 project sites withdrew 2 years after enrollment 
ended, this is unlikely to have had much influence on our findings because the denominators 
used for our tuberculosis incidence rates were based on the number of contacts during a 
given period. Furthermore, this site had very low enrollment, so the effect on the overall 
tuberculosis rates among contacts is expected to be quite small, particularly since registry 
match data for this site were available for the first 2 years after enrollment, when 
tuberculosis rates are highest. Other limitations include our inability to determine with 
certainty the source case for contacts with tuberculosis, the possibility that tuberculosis 
registry matches failed to detect contacts who moved out of state or used a different name, 
and the fact that contacts who were treated for LTBI may have been those at highest risk for 
tuberculosis. Although we did not directly assess the impact of LTBI treatment on the rates 
and timing of tuberculosis, we present data both for all contacts and for the subset of 
untreated TST-positive contacts. Although the rates are somewhat higher in the latter group, 
the timing is quite similar. Furthermore, our findings that most secondary cases occur quite 
rapidly and could not have been prevented even with timely contact investigation, the fact 
that only one third of contacts with LTBI completed treatment [27], and evidence that most 
contacts who initiated treatment did so >3 months after exposure [24] (when the risk of 
progression to tuberculosis is already lower) suggest that the impact of LTBI treatment on 
the rates and timing of tuberculosis we present in this report is not expected to be large. 
Study strengths include the large number of contacts with tuberculosis included in our study, 
the use of registry matches, the long follow-up period, the prospective and protocol-driven 
nature of our data collection, and the ability to prospectively collect information on many 
epidemiologic factors, including hours of exposure.
In conclusion, our prospective study provides important new information on the risk of 
tuberculosis over time in recent contacts of patients with infectious tuberculosis. Our 
findings support the important role of contact investigation as a means of identifying and 
treating new cases of active tuberculosis among contacts, and they underscore the 
importance of rapid screening and initiation of treatment for LTBI. These findings have 
important implications for tuberculosis prevention efforts worldwide, as well as for the 
design and interpretation of clinical trials of preventive therapeutic regimens.
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Figure 1. 
Timing of tuberculosis (defined as the interval from index case treatment initiation to contact 
treatment initiation) among 131 contacts, by interval from index case treatment initiation; 
the 27 contacts in whom tuberculosis was diagnosed before the index cases received a 
diagnosis are excluded. Of note, tuberculosis registry matches were used to identify the 
diagnosis of tuberculosis among enrolled contacts after contact investigations were 
completed; tuberculosis registry matches were performed annually for 4 years after last site 
enrollment at 8 sites and annually for 2 years at one site. Since enrollment occurred over a 4-
year period, contacts enrolled earlier in the study had a longer tuberculosis registry match 
observation period, with 100%, 94%, 76%, 55%, and 34% observed for 4, 5, 6, 7, and 8 
years, respectively, after enrollment.
Reichler et al. Page 11
J Infect Dis. Author manuscript; available in PMC 2019 May 24.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
Figure 2. 
Disease-free survival for 4490 contacts (158 with and 4332 without tuberculosis), by age 
group (A), screening tuberculin skin test (TST) result (B), and receipt of treatment for latent 
Mycobacterium tuberculosis infection (C). Tuberculosis registry matches were performed 
annually for 4 years after last site enrollment at 8 sites and annually for 2 years at 1 site. 
Since enrollment occurred over a 4-year period, contacts enrolled earlier in the study had a 
longer tuberculosis registry match observation period, with 100% and 94% observed for 4 
and 5 years, respectively. Neg, negative; pos, positive; PT, preventive therapy.
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Table 1.
Characteristics of 158 Contacts With a Diagnosis of Tuberculosis
Characteristic Overall, No. (%)(n = 158) Coprevalent, No. (%)(n = 81) Incident, No. (%)(n = 77)
Age, y
  0–5  49 (31) 29 (36) 20 (26)
  6–14  8 (5) 6 (7) 2 (3)
  15–24  26 (16) 11 (14) 15 (19)
  25–44  42 (27) 25 (31) 17 (22)
  45–64  28 (18)  8 (10) 20 (26)
  ≥65  3 (2) 2 (2) 1 (1)
Sex
  Male  87 (55) 42 (52) 45 (58)
  Female  71 (45) 39 (48) 32 (42)
Race
  White  9 (6) 3 (4) 6 (8)
  Black  95 (60) 51 (63) 44 (57)
  Asian/Pacific Islander  16 (10) 6 (7) 10 (63)
  Hispanic  30 (19) 19 (23) 11 (14)
  Other  8 (5) 2 (2) 6 (8)
Birthplace
  US/Canada 123 (78) 62 (77) 61 (79)
  Other  35 (22) 19 (23) 16 (21)
HIV status
  Positive  4 (3) 3 (4) 1 (1)
  Negative  54 (34) 24 (30) 30 (39)
  Unknown 100 (63) 54 (67) 46 (60)
TST screening result
  Negative  6 (4) 3 (4) 3 (4)
  Positive 115 (73) 57 (70) 58 (75)
  Othera  37 (23) 21 (26) 16 (21)
Place of contact
  Household 115 (73) 64 (79) 51 (66)
  Workplace  9 (6) 1 (1)  8 (10)
  Social place  26 (16) 14 (17) 12 (16)
  School  8 (5) 2 (2) 6 (8)
Means of identification
  Contact investigation 121 (77) 69 (85) 52 (68)
  Registry match  37 (23) 12 (15) 25 (32)
Contacts were categorized as having coprevalent tuberculosis if disease was diagnosed before, at the same time as, or ≤1 month after the index 
cases’ tuberculosis diagnosis and as having incident tuberculosis if disease was diagnosed >30 days after the index cases’ diagnosis.
Abbreviations: HIV, human immunodeficiency virus; TST, tuberculin skin test.
aNot screened, partially screened, not eligible for screening, or unknown screening
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